Regulatory

21 CFR Part 11

FDA regulation on electronic records and signatures.

21 CFR Part 11 is the FDA regulation establishing criteria under which electronic records and electronic signatures are acceptable as paper equivalents for FDA-regulated studies. Requires system validation, audit trail, access controls, and dual-component signatures.